China Inhalation Anesthesia Market Size & Outlook
China inhalation anesthesia market, 2018-2030 (US$M)
Related Markets
China inhalation anesthesia market highlights
- The China inhalation anesthesia market generated a revenue of USD 47.4 million in 2022 and is expected to reach USD 104.2 million by 2030.
- The China market is expected to grow at a CAGR of 10.4% from 2023 to 2030.
- In terms of segment, sevoflurane was the largest revenue generating drug in 2022.
- Isoflurane is the most lucrative drug segment registering the fastest growth during the forecast period.
Inhalation anesthesia market data book summary
| Market revenue in 2022 | USD 47.4 million |
| Market revenue in 2030 | USD 104.2 million |
| Growth rate | 10.4% (CAGR from 2022 to 2030) |
| Largest segment | Sevoflurane |
| Fastest growing segment | Isoflurane |
| Historical data | 2016 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Sevoflurane, Desflurane, Isoflurane, Halothane |
| Key market players worldwide | Baxter International Inc, AbbVie Inc, Fresenius SE & Co KGaA, Sandoz Group AG ADR, Piramal Enterprises, Halocarbon Products Corporation, Lunan Pharmaceutical Group |
Other key industry trends
- In terms of revenue, China accounted for 3.9% of the global inhalation anesthesia market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China inhalation anesthesia market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 104.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Inhalation Anesthesia Market Scope
Inhalation Anesthesia Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China inhalation anesthesia market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalation anesthesia market will help companies and investors design strategic landscapes.
Sevoflurane was the largest segment with a revenue share of 62.24% in 2024. Horizon Databook has segmented the China inhalation anesthesia market based on sevoflurane, desflurane, isoflurane, halothane covering the revenue growth of each sub-segment from 2018 to 2030.
China is the largest economy in the Asia Pacific region and possesses the highest population globally, resulting in a substantial patient pool for surgical procedures. The high volume of surgeries performed, coupled with this large patient demographic, is expected to drive market growth.
During the forecast period. According to the World Bank, China's population reached 1.386 billion. The increasing disease prevalence is driving the market opportunity.
Reasons to subscribe to China inhalation anesthesia market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China inhalation anesthesia market databook
-
Our clientele includes a mix of inhalation anesthesia market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China inhalation anesthesia market , including forecasts for subscribers. This country databook contains high-level insights into China inhalation anesthesia market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China inhalation anesthesia market size, by drug, 2018-2030 (US$M)
China Inhalation Anesthesia Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
